Related Experiment Video
Updated: Jun 8, 2025
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
383
NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c-Myc/p27 Signaling Pathway
Jiachen Li1, Yaojie Wang2,3, Sisi Wei2,3
1Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Molecular Carcinogenesis
|November 6, 2024
Summary
Never in mitosis gene A (NIMA)-related kinase 2 (NEK2) is upregulated in esophageal squamous cell carcinoma (ESCC). NEK2 inhibition suppresses ESCC progression by affecting proliferation, migration, and invasion via the FOXM1/c-Myc/p27 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Never in mitosis gene A (NIMA)-related kinase 2 (NEK2) is a serine-threonine kinase vital for cell mitosis.
- The specific role of NEK2 in esophageal squamous cell carcinoma (ESCC) pathogenesis is not fully elucidated.
- Understanding NEK2's function in ESCC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression and function of NEK2 in ESCC.
- To determine the relationship between NEK2 expression and patient prognosis.
- To elucidate the molecular mechanisms by which NEK2 influences ESCC progression.
Main Methods:
- Bioinformatics analysis, RT-qPCR, and immunohistochemistry were used to assess NEK2 expression in ESCC tissues.
- In vitro assays (cell proliferation, colony formation, migration, invasion) and in vivo xenograft models were employed to study NEK2 knockdown effects.
- Western blotting and signaling pathway analysis identified downstream targets and mechanisms.
Main Results:
- NEK2 expression is significantly upregulated in ESCC tissues and correlates with poor patient prognosis.
- NEK2 knockdown inhibited ESCC cell proliferation, migration, and invasion in vitro and reduced tumor growth in vivo.
- NEK2 promotes ESCC progression by activating the FOXM1/c-Myc/p27 signaling pathway, inhibiting cellular senescence.
Conclusions:
- NEK2 is a key driver of ESCC progression, acting through the FOXM1/c-Myc/p27 pathway.
- Targeting NEK2 may offer a novel therapeutic strategy for managing esophageal squamous cell carcinoma.
- NEK2 inhibition presents a promising avenue for improving outcomes in ESCC patients.
Related Concept Videos
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K